Amphion Innovations (AMP)

 

Latest News

Holding(s) in Company

RNS Number: 6347R Motif Bio PLC 25 September 2017 25 September 2017 Motif Bio plc ("Motif" or the "Group") Holding(s) in the Company Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 22 September 2017 by Amphion Innovations plc ("Amphion") that a tot...

Sale of Partner Company Shares

RNS Number: 6345R Amphion Innovations PLC 25 September 2017 Amphion Innovations plc ("Amphion" or "the Company") Sale of Partner Company Shares London and New York: Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that 4,390,000 shares in Partner Company, Motif Bio have been sold...

Amphion reduces stake in Motif Bio

Amphion Innovations has soled 1,700,000 shares in partner company, Motif Bio, in partial repayment of the loan facility or...

Sale of partner company shares

RNS Number: 2325P Amphion Innovations PLC 30 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 30 August 2017 Sale of Partner Company Shares London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that 1,700,000 shares in Partner Company, Motif ...

All News

DateHeadlineSource
09-12-10New Debt FacilityRNS
25-10-10Partner UpdateRNS
18-10-10Director/PDMR ShareholdingRNS
30-09-10Total Voting RightsRNS
24-09-10IP LicensingRNS
22-09-10Grant Win by Partner CompanyRNS
10-09-10Half Yearly ReportRNS
08-09-10Issue of EquityRNS

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory